Literature DB >> 24487640

Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling.

Janet L Crane, Xu Cao.   

Abstract

During bone resorption, abundant factors previously buried in the bone matrix are released into the bone marrow microenvironment, which results in recruitment and differentiation of bone marrow mesenchymal stem cells (MSCs) for subsequent bone formation, temporally and spatially coupling bone remodeling. Parathyroid hormone (PTH) orchestrates the signaling of many pathways that direct MSC fate. The spatiotemporal release and activation of matrix TGF-β during osteoclast bone resorption recruits MSCs to bone-resorptive sites. Dysregulation of TGF-β alters MSC fate, uncoupling bone remodeling and causing skeletal disorders. Modulation of TGF-β or PTH signaling may reestablish coupled bone remodeling and be a potential therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487640      PMCID: PMC3904610          DOI: 10.1172/JCI70050

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  117 in total

1.  Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.

Authors:  N Miyakoshi; Y Kasukawa; T A Linkhart; D J Baylink; S Mohan
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

Review 2.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

3.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.

Authors:  Dongsu Park; Joel A Spencer; Bong Ihn Koh; Tatsuya Kobayashi; Joji Fujisaki; Thomas L Clemens; Charles P Lin; Henry M Kronenberg; David T Scadden
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  Activation of the bone-derived latent TGF beta complex by isolated osteoclasts.

Authors:  R O Oreffo; G R Mundy; S M Seyedin; L F Bonewald
Journal:  Biochem Biophys Res Commun       Date:  1989-02-15       Impact factor: 3.575

5.  Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells.

Authors:  T Sobue; T Gravely; A Hand; Y K Min; C Pilbeam; L G Raisz; X Zhang; D Larocca; R Florkiewicz; M M Hurley
Journal:  J Bone Miner Res       Date:  2002-03       Impact factor: 6.741

6.  Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.

Authors:  Robert L Jilka; Maria Almeida; Elena Ambrogini; Li Han; Paula K Roberson; Robert S Weinstein; Starros C Manolagas
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

7.  Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

Authors:  Vidya Ganapathy; Rongrong Ge; Alison Grazioli; Wen Xie; Whitney Banach-Petrosky; Yibin Kang; Scott Lonning; John McPherson; Jonathan M Yingling; Swati Biswas; Gregory R Mundy; Michael Reiss
Journal:  Mol Cancer       Date:  2010-05-26       Impact factor: 27.401

Review 8.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

9.  Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2.

Authors:  S Klein; A Bikfalvi; T M Birkenmeier; F G Giancotti; D B Rifkin
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

Review 10.  The hematopoietic stem cell niche.

Authors:  Dongsu Park; David B Sykes; David T Scadden
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01
View more
  138 in total

1.  The effects of different intensities of exercise and active vitamin D on mouse bone mass and bone strength.

Authors:  Lingli Zhang; Xi Chen; Juanni Wu; Yu Yuan; Jianmin Guo; Soma Biswas; Baojie Li; Jun Zou
Journal:  J Bone Miner Metab       Date:  2016-06-29       Impact factor: 2.626

2.  Role of MSC-derived galectin 3 in the AML microenvironment.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Jared K Burks; YiHua Qiu; Rui-Yu Wang; Elizabeth J Shpall; Leonardo Mirandola; Numsen Hail; Zhihong Zeng; Teresa McQueen; Naval Daver; Sean M Post; Maurizio Chiriva-Internati; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-12       Impact factor: 4.739

3.  Parathyroid hormone: critical bridge between bone metabolism and cardiovascular disease.

Authors:  Claudia Goettsch; Hiroshi Iwata; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07       Impact factor: 8.311

Review 4.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.

Authors:  Ying Wang; Xiaodong Chen; Wei Cao; Yufang Shi
Journal:  Nat Immunol       Date:  2014-11       Impact factor: 25.606

Review 5.  Coupling factors involved in preserving bone balance.

Authors:  Beom-Jun Kim; Jung-Min Koh
Journal:  Cell Mol Life Sci       Date:  2018-12-04       Impact factor: 9.261

Review 6.  Regulatory mechanisms of sclerostin expression during bone remodeling.

Authors:  Masanori Koide; Yasuhiro Kobayashi
Journal:  J Bone Miner Metab       Date:  2018-10-24       Impact factor: 2.626

Review 7.  Molecular and cellular basis of bone resorption.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2014-09-16

8.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

9.  The platelet: sensing shear and the endocrine regulation of cardiovascular sclerosis.

Authors:  Dwight A Towler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

Review 10.  More than the genes, the tumor microenvironment in neuroblastoma.

Authors:  Lucia Borriello; Robert C Seeger; Shahab Asgharzadeh; Yves A DeClerck
Journal:  Cancer Lett       Date:  2015-11-17       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.